Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-03-13 @ 6:28 AM
Study NCT ID:
NCT00865033
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2009-03-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions
Sponsor:
Sandoz
Organization:
Study Overview
Official Title:
A Relative Bioavailability Study of Metformin HCL 1000 mg Tablets Under Fasting Conditions
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to demonstrate the relative bioequivalence of Metformin HCL Tablets, 1000 mg under fasting conditions.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: